{
    "clinical_study": {
        "@rank": "139792", 
        "brief_summary": {
            "textblock": "RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in\n      chemotherapy use different ways to stop tumor cells from dividing so they stop growing or\n      die. It is not yet known whether radiation therapy with chemotherapy is more effective than\n      radiation therapy alone in treating high-risk endometrial cancer.\n\n      PURPOSE: This randomized phase III trial is studying radiation therapy and chemotherapy to\n      see how well they work compared to radiation therapy alone in treating patients with\n      high-risk endometrial cancer."
        }, 
        "brief_title": "Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer", 
        "completion_date": {
            "#text": "July 2010", 
            "@type": "Actual"
        }, 
        "condition": "Endometrial Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Endometrial Neoplasms", 
                "Sarcoma, Endometrial Stromal"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Compare relapse-free survival of patients with high-risk endometrial carcinoma treated\n           in the adjuvant setting with either radiotherapy alone or radiotherapy and chemotherapy\n           given sequentially.\n\n        -  Compare overall survival of this patient population treated with these 2 adjuvant\n           regimens.\n\n        -  Evaluate the addition of chemotherapy to standard adjuvant radiotherapy, in terms of\n           toxicity, in these patients.\n\n        -  Study whether the pattern of relapse in these patients is influenced by the addition of\n           chemotherapy to adjuvant radiotherapy.\n\n      OUTLINE: This is a randomized, open-label, multicenter study. Patients are stratified\n      according to center and histologic type (serous papillary and clear cell vs all other\n      types). Patients are randomized to 1 of 2 treatment arms.\n\n      All patients undergo hysterectomy with bilateral salpingooophorectomy and extirpation of\n      macroscopic suspicious lymph nodes.\n\n        -  Arm I: Within 7 weeks after surgery, patients begin radiotherapy.\n\n        -  Arm II: Patients receive radiotherapy followed by or preceded by chemotherapy*.\n           Patients receive cisplatin IV over 60 minutes and doxorubicin or epirubicin IV over\n           10-20 minutes on day 1. Treament repeats every 21 days for 4 courses.\n\n      NOTE: *If radiotherapy is preceded by chemotherapy, radiotherapy begins within 4 weeks after\n      chemotherapy.\n\n      Patients are followed at 3 and 6 months and then every 6 months for 5 years.\n\n      PROJECTED ACCRUAL: A total of 400 patients (200 per treatment arm) will be accrued for this\n      study within 5 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically confirmed endometrial cancer of 1 of the following types:\n\n               -  Clear cell carcinoma\n\n               -  Serous papillary carcinoma\n\n               -  Undifferentiated (anaplastic) carcinoma\n\n               -  Poorly differentiated (FIGO grade 3) adenocarcinoma with infiltration to more\n                  than half the myometrial thickness\n\n          -  No small cell carcinoma with neuroendocrine differentiation\n\n          -  Primary in FIGO surgical stage I or occult stage II\n\n          -  No spread of disease outside the uterine corpus except to pelvic lymph nodes\n\n               -  No spread of disease to para-aortic lymph nodes\n\n          -  Positive peritoneal washings allowed\n\n          -  No preoperative macroscopic tumor involvement of the cervix\n\n               -  Microscopic tumor involvement of the cervix on histopathological evaluation of\n                  the operative uterine specimen allowed\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Any age\n\n        Performance status:\n\n          -  WHO 0-2\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Adequate bone marrow function\n\n          -  WBC at least 3,500/mm^3\n\n          -  Platelet count at least 100,000/mm^3\n\n        Hepatic:\n\n          -  Adequate hepatic function\n\n        Renal:\n\n          -  Adequate renal function\n\n          -  Creatinine no greater than 1.4 mg/dL\n\n        Pulmonary:\n\n          -  Adequate pulmonary function\n\n        Other:\n\n          -  Not pregnant or nursing\n\n          -  Fit to receive combination chemotherapy\n\n          -  No other malignancy except basal cell or squamous cell skin cancer\n\n          -  No uncontrolled or potentially active site of infection (e.g., fistula or abscesses)\n\n          -  No other concurrent condition that would produce a substantial increase in risk for\n             complications from radiotherapy\n\n          -  No other concurrent condition that would interfere with adequate follow-up\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  Not specified\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  No prior preoperative irradiation\n\n        Surgery:\n\n          -  No prior extensive abdominal surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 2, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00005583", 
            "org_study_id": "NSGO-EC9501", 
            "secondary_id": [
                "CDR0000067646", 
                "EORTC-55991"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "cisplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "epirubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "adjuvant therapy", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "conventional surgery", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "radiation therapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cisplatin", 
                "Doxorubicin", 
                "Epirubicin"
            ]
        }, 
        "keyword": [
            "stage I endometrial carcinoma", 
            "stage II endometrial carcinoma", 
            "endometrial adenocarcinoma", 
            "endometrial papillary serous carcinoma", 
            "endometrial clear cell carcinoma"
        ], 
        "lastchanged_date": "August 1, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/NSGO-EC9501"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1000"
                    }, 
                    "name": "Institut Jules Bordet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kortrijk", 
                        "country": "Belgium", 
                        "zip": "B-8500"
                    }, 
                    "name": "Cazk Groeninghe - Campus Maria's Voorzienigheid"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76038"
                    }, 
                    "name": "Centre Henri Becquerel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland", 
                        "zip": "8"
                    }, 
                    "name": "Coombe Women's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland", 
                        "zip": "8"
                    }, 
                    "name": "St. James's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naples", 
                        "country": "Italy", 
                        "zip": "80131"
                    }, 
                    "name": "Istituto Nazionale per lo Studio e la Cura dei Tumori"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parma", 
                        "country": "Italy", 
                        "zip": "43100"
                    }, 
                    "name": "Azienda Ospedaliera Di Parma"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pavia", 
                        "country": "Italy", 
                        "zip": "27100"
                    }, 
                    "name": "Fondazione I.R.C.C.S. Policlinico San Matteo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varese", 
                        "country": "Italy", 
                        "zip": "21100"
                    }, 
                    "name": "Ospedale di Circolo e Fondazione Macchi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1091 HA"
                    }, 
                    "name": "Onze Lieve Vrouwe Gasthuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Enschede", 
                        "country": "Netherlands", 
                        "zip": "7500 KA"
                    }, 
                    "name": "Medisch Spectrum Twente"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6500 HB"
                    }, 
                    "name": "Universitair Medisch Centrum St. Radboud - Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "N-0310"
                    }, 
                    "name": "Norwegian Radium Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gdansk", 
                        "country": "Poland", 
                        "zip": "80-211"
                    }, 
                    "name": "Medical University of Gdansk"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Coimbra", 
                        "country": "Portugal", 
                        "zip": "3049"
                    }, 
                    "name": "Hospitais da Universidade de Coimbra (HUC)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "zip": "7925"
                    }, 
                    "name": "Groote Schuur Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28040"
                    }, 
                    "name": "Hospital Universitario San Carlos"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oviedo", 
                        "country": "Spain", 
                        "zip": "33006"
                    }, 
                    "name": "Hospital Universitario Central de Asturias"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NG5 1PB"
                    }, 
                    "name": "Nottingham City Hospital NHS Trust"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belfast", 
                        "country": "United Kingdom", 
                        "state": "Northern Ireland", 
                        "zip": "BT9 7AB"
                    }, 
                    "name": "Centre for Cancer Research and Cell Biology at Belfast City Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G11 6NT"
                    }, 
                    "name": "Western Infirmary"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "France", 
                "Ireland", 
                "Italy", 
                "Netherlands", 
                "Norway", 
                "Poland", 
                "Portugal", 
                "South Africa", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "official_title": "A Randomized Trial of Adjuvant Treatment With Radiation Plus Chemotherapy Versus Radiation Alone in High Risk Endometrial Carcinoma", 
        "overall_official": [
            {
                "affiliation": "Norwegian Radium Hospital", 
                "last_name": "Gunnar B. Kristensen, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospitais da Universidade de Coimbra (HUC)", 
                "last_name": "Carlos F. de Oliveira, MD, PhD"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_outcome": [
            {
                "measure": "Progression-free survival", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Relapse-free survival", 
                "safety_issue": "No"
            }
        ], 
        "reference": {
            "PMID": "20619634", 
            "citation": "Hogberg T, Signorelli M, de Oliveira CF, Fossati R, Lissoni AA, Sorbe B, Andersson H, Grenman S, Lundgren C, Rosenberg P, Boman K, Tholander B, Scambia G, Reed N, Cormio G, Tognon G, Clarke J, Sawicki T, Zola P, Kristensen G. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-Results from two randomised studies. Eur J Cancer. 2010 Jul 7; [Epub ahead of print]"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00005583"
        }, 
        "results_reference": {
            "citation": "Hogberg T, Rosenberg P, Kristensen G, et al.: A randomized phase-III study on adjuvant treatment with radiation (RT) \u00b1 chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). [Abstract] J Clin Oncol 25 (Suppl 18): A-5503, 274s, 2007."
        }, 
        "secondary_outcome": {
            "measure": "Overall survival", 
            "safety_issue": "No"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "collaborator": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Nordic Society for Gynaecologic Oncology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2000", 
        "study_design": "Allocation: Randomized, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2006"
    }, 
    "geocoordinates": {
        "Azienda Ospedaliera Di Parma": "44.808 10.33", 
        "Cazk Groeninghe - Campus Maria's Voorzienigheid": "50.831 3.264", 
        "Centre Henri Becquerel": "49.443 1.1", 
        "Centre for Cancer Research and Cell Biology at Belfast City Hospital": "54.597 -5.934", 
        "Coombe Women's Hospital": "53.344 -6.267", 
        "Fondazione I.R.C.C.S. Policlinico San Matteo": "45.186 9.157", 
        "Groote Schuur Hospital": "-33.925 18.424", 
        "Hospitais da Universidade de Coimbra (HUC)": "40.211 -8.429", 
        "Hospital Universitario Central de Asturias": "43.36 -5.845", 
        "Hospital Universitario San Carlos": "40.417 -3.7", 
        "Institut Jules Bordet": "50.85 4.352", 
        "Istituto Nazionale per lo Studio e la Cura dei Tumori": "40.84 14.253", 
        "Medical University of Gdansk": "54.352 18.647", 
        "Medisch Spectrum Twente": "52.222 6.894", 
        "Norwegian Radium Hospital": "59.914 10.752", 
        "Nottingham City Hospital NHS Trust": "52.955 -1.158", 
        "Onze Lieve Vrouwe Gasthuis": "52.37 4.895", 
        "Ospedale di Circolo e Fondazione Macchi": "45.818 8.826", 
        "St. James's Hospital": "53.344 -6.267", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Universitair Medisch Centrum St. Radboud - Nijmegen": "51.843 5.855", 
        "Universitair Ziekenhuis Antwerpen": "51.153 4.438", 
        "Western Infirmary": "55.864 -4.252"
    }
}